Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company

Clinical trials sponsored by Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company, explained in plain language.

Not yet finished but already full! 1

New radiation therapy shows promise for Tough-to-Treat prostate cancer

Disease control Ongoing

This study tests a new treatment called Lu-177-PNT2002 for men with a type of advanced prostate cancer that no longer responds to hormone therapy. The treatment delivers radiation directly to cancer cells using a targeting molecule. About 455 men will participate to see if it slo…

Phase: PHASE3 • Sponsor: POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company • Aim: Disease control

Last updated May 17, 2026 06:50 UTC